NASDAQ:JYNT - The Joint Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $51.20
  • Forecasted Upside: -3.05 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$52.81
▲ +0.34 (0.65%)
1 month | 3 months | 12 months
Get New The Joint Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for JYNT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for JYNT

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$51.20
▼ -3.05% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for The Joint in the last 3 months. The average price target is $51.20, with a high forecast of $60.00 and a low forecast of $38.00. The average price target represents a -3.05% upside from the last price of $52.81.
Buy
The current consensus among 5 contributing investment analysts is to buy stock in The Joint. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/21/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/19/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/13/2021DA DavidsonBoost Price TargetBuy$54.00 ➝ $57.00N/A
i
4/7/2021DA DavidsonBoost Price TargetBuy$54.00 ➝ $57.00Low
i
3/11/2021DA DavidsonBoost Price TargetBuy$33.00 ➝ $54.00Medium
i
3/5/2021Lake Street CapitalBoost Price TargetBuy$35.00 ➝ $60.00Medium
i
3/5/2021DA DavidsonBoost Price TargetPositive ➝ Buy$33.00 ➝ $54.00Medium
i
3/5/2021Maxim GroupBoost Price TargetBuy$28.00 ➝ $54.00Medium
i
2/25/2021B. RileyBoost Price TargetBuy$26.00 ➝ $47.00Medium
i
1/6/2021Craig HallumBoost Price Target$26.00 ➝ $38.00N/A
i
1/4/2021Lake Street CapitalBoost Price TargetBuy$25.00 ➝ $35.00N/A
i
11/9/2020DA DavidsonBoost Price TargetBuy$21.00 ➝ $31.00High
i
11/6/2020Maxim GroupReiterated RatingBuy$28.00High
i
Rating by Anthony Vendetti at Maxim Group
11/6/2020B. RileyBoost Price Target$22.00 ➝ $26.00Low
i
8/7/2020Maxim GroupReiterated RatingBuy$22.00High
i
Rating by Anthony Vendetti at Maxim Group
6/25/2020Craig HallumInitiated CoverageBuy$24.00High
i
Rating by Jeremy Hamblin at Craig Hallum
6/11/2020DA DavidsonBoost Price TargetBuy$17.00 ➝ $21.00Medium
i
5/8/2020Maxim GroupReiterated RatingBuy$22.00Medium
i
Rating by Anthony Vendetti at Maxim Group
3/27/2020B. RileyLower Price TargetBuy$26.00 ➝ $20.00High
i
Rating by Jeff Van Sinderen at B. Riley
3/6/2020Maxim GroupReiterated RatingBuy$25.00High
i
3/6/2020B. RileyBoost Price TargetBuy$25.00 ➝ $26.00High
i
Rating by Jeff Van Sinderen at B. Riley
1/10/2020B. RileyReiterated RatingBuy$25.00Low
i
Rating by Jeff Van Sinderen at B. Riley
11/12/2019DA DavidsonBoost Price TargetBuy$23.00 ➝ $32.00High
i
Rating by L. Weiser at DA Davidson
11/8/2019Maxim GroupReiterated RatingBuy$25.00High
i
Rating by Anthony Vendetti at Maxim Group
11/4/2019DA DavidsonReiterated RatingBuyLow
i
Rating by L. Weiser at DA Davidson
8/9/2019B. RileySet Price TargetBuy$23.00Medium
i
Rating by Jeff Van Sinderen at B. Riley
8/9/2019Maxim GroupReiterated RatingBuy$25.00Medium
i
8/9/2019Lake Street CapitalBoost Price TargetBuy$20.00 ➝ $30.00High
i
Rating by Brooks O'Neil at Lake Street Capital
6/20/2019B. RileyInitiated CoverageBuy ➝ Buy$23.00High
i
Rating by J. Van. Sinderen at B. Riley
6/3/2019Roth CapitalBoost Price TargetBuy$16.00 ➝ $23.00Medium
i
5/23/2019DA DavidsonSet Price TargetBuy$21.00Low
i
Rating by Michael Kawamoto at DA Davidson
4/5/2019DA DavidsonBoost Price TargetBuy$20.00High
i
Rating by Michael Kawamoto at DA Davidson
3/8/2019DA DavidsonBoost Price TargetBuy$15.00High
i
Rating by M. Kawamoto at DA Davidson
3/8/2019Lake Street CapitalBoost Price TargetBuy$20.00High
i
3/8/2019Maxim GroupReiterated RatingBuy ➝ Buy$11.00 ➝ $18.00High
i
1/17/2019DA DavidsonInitiated CoverageBuy ➝ Buy$10.00Low
i
Rating by M. Kawamoto at DA Davidson
8/10/2018Roth CapitalReiterated RatingBuyLow
i
Rating by D. Bain at Roth Capital
6/7/2018Roth CapitalBoost Price TargetBuy$7.75 ➝ $12.00Low
i
5/11/2018Maxim GroupReiterated RatingBuy$10.00High
i
4/12/2018Maxim GroupBoost Price TargetBuy ➝ Buy$7.00 ➝ $9.00Low
i
3/28/2018Lake Street CapitalInitiated CoverageBuyHigh
i
3/9/2018Maxim GroupReiterated RatingBuy$7.00High
i
8/11/2017Maxim GroupReiterated RatingBuy$7.00Medium
i
7/27/2017Roth CapitalInitiated CoverageBuy ➝ Buy$5.70Low
i
Rating by D. Bain at Roth Capital
6/14/2017Craig HallumInitiated CoverageBuy$5.75High
i
3/10/2017Feltl & Co.Reiterated RatingBuyMedium
i
Rating by M. Smith at Feltl & Co.
3/10/2017Maxim GroupReiterated RatingBuy ➝ Buy$5.00 ➝ $7.00High
i
7/1/2016Maxim GroupLower Price TargetBuy$8.00 ➝ $5.00N/A
i
Rating by Anthony Vendetti at Maxim Group
6/24/2016Feltl & Co.DowngradeStrong-Buy ➝ BuyN/A
i
Rating by B. Rystrom at Feltl & Co.
(Data available from 4/19/2016 forward)
The Joint logo
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of December 31, 2020, the company operated approximately 515 clinics operated or managed by franchisees and 64 company-owned or managed clinics in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Read More

Today's Range

Now: $52.81
$52.00
$52.99

50 Day Range

MA: $45.35
$38.38
$53.00

52 Week Range

Now: $52.81
$10.23
$54.11

Volume

82,371 shs

Average Volume

156,849 shs

Market Capitalization

$746.73 million

P/E Ratio

195.60

Dividend Yield

N/A

Beta

1.27

Frequently Asked Questions

What sell-side analysts currently cover shares of The Joint?

The following sell-side analysts have issued reports on The Joint in the last twelve months: B. Riley, Craig Hallum, DA Davidson, Lake Street Capital, Maxim Group, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for JYNT.

What is the current price target for The Joint?

5 Wall Street analysts have set twelve-month price targets for The Joint in the last year. Their average twelve-month price target is $51.20, suggesting a possible downside of 3.0%. Lake Street Capital has the highest price target set, predicting JYNT will reach $60.00 in the next twelve months. Craig Hallum has the lowest price target set, forecasting a price of $38.00 for The Joint in the next year.
View the latest price targets for JYNT.

What is the current consensus analyst rating for The Joint?

The Joint currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe JYNT will outperform the market and that investors should add to their positions of The Joint.
View the latest ratings for JYNT.

What other companies compete with The Joint?

How do I contact The Joint's investor relations team?

The Joint's physical mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company's listed phone number is 480-245-5960 and its investor relations email address is [email protected] The official website for The Joint is www.thejoint.com.